We focus on the mechanisms by which both HCV infection and IFNα treatment may contribute to the development of T2D and T1D (in this review, we refer to all forms of autoimmune diabetes as T1D), and the mechanisms by which diabetes can worsen outcomes in HCV infection. The gene discussed is IFNA1; the disease is type 2 diabetes mellitus.